10
Participants
Start Date
May 31, 2012
Primary Completion Date
December 31, 2012
Study Completion Date
December 31, 2012
2011-2012 Fluzone IIV3 (IM)
2011-2012 Fluzone IIV3 vaccine delivered intramuscularly (IM)
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Stanford University
OTHER